Dexmedetomidine vs. Remifentanil Conscious Sedation for Stapedotomy/Stapedectomy
Dexmedetomidine continuous intravenous infusion vs. remifentanil target-controlled infusion conscious sedation for stapedotomy/stapedectomy- a prospective, single-center, double-masked randomized trial

The goal of this clinical trial is to compare monitored anesthesia care with continuous intravenous dexmedetomidine vs. remifentanil target-controlled infusion in patients undergoing stapedotomy or stapedectomy for otosclerosis. The aims of this research are:

to assess the patient's satisfaction with each sedation regimen
the surgeon will also grade their satisfaction regarding the surgical field The investigators will monitor and analyze the vitals during and after the intervention and document any intra- and postoperative complications.

Participants will be randomly assigned to receive either dexmedetomidine or remifentanil, and the patient, the surgeon, and the investigator will not be aware of the treatment administered.
- EligibilityCriteria: Inclusion Criteria:  otosclerosis surgery, ASA ( American Society of Anesthesiologists) status 1-2  Exclusion Criteria:  ASA status 3-4 requiring general anesthesia refusing to participate allergic to study medication - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 65 Years - StdAgeList: Adult, Older Adult